Carlos F. Barbas III

Carlos F. Barbas III

Professor of Chemistry and Molecular and Cell Biology,The Scripps Research Institute
在 scripps.edu 的电子邮件经过验证
被引用次数：72226
organocatalysis zinc fingers antibody therapeutics cancer therapy HIV therapy
Paul J. Carter

Paul J. Carter

Genentech
在 gene.com 的电子邮件经过验证
被引用次数：25867
Antibody therapeutics antibody engineering
E. Sally Ward

E. Sally Ward

Texas A&M University
在 tamu.edu 的电子邮件经过验证
被引用次数：23726
Immunology Cancer Biology Antibody Engineering Antibody Therapeutics
Stuart Cook

Stuart Cook

Imperial College, Duke-NUS, MRC-LMS
在 imperial.ac.uk 的电子邮件经过验证
被引用次数：23102
Ageing Regeneration Antibody therapeutics
Henry Lowman

Henry Lowman

在 triphaseco.com 的电子邮件经过验证
被引用次数：19495
biochemistry phage display antibody therapeutics oncology protein engineering
Maneesh Jain

Maneesh Jain

Professor, University of Nebraska Medical Center
在 unmc.edu 的电子邮件经过验证
被引用次数：14284
Cancer Immunology Antibody therapeutics Pancreatic cancer Tumor Microenvironment
Zhiqiang An

Zhiqiang An

Professor of Molecular Medicine, University of Texas Health Science Center at Houston
在 uth.tmc.edu 的电子邮件经过验证
被引用次数：13159
antibody therapeutics antibiotics cancer biology microbial natural products
Christoph Rader

Christoph Rader

Chief Technology Officer, Aethon Therapeutics, Inc.
在 aethontx.com 的电子邮件经过验证
被引用次数：12659
Antibody Therapeutics Antibody Engineering Phage Display Antibody-Drug Conjugates Bispecific Antibodies
Janice Reichert

Janice Reichert

The Antibody Society
在 reichertbiotechconsulting.com 的电子邮件经过验证
被引用次数：12487
Antibody therapeutics
Mike Clark

Mike Clark

Retired (30th Sept 2014) as Reader in Therapeutic and Molecular Immunology, Cambridge …
在 cam.ac.uk 的电子邮件经过验证
被引用次数：11878
Immunology biotechnology immunotherapy antibody therapeutics antibodies
1 - 10